Dechert advised Abivax, Reed Smith advised Claret Capital Partners and Reinhart Marville Torre accompanied Kreos Capital and Claret Capital Partners in their investment. Abivax announced structured debt...
Abivax’s €150 Million Financing
Abivax’s EUR 130 Million Cross-Over Financing
Gide advised financial advisers SVB Securities, LifeSci Capital and Bryan and Garnier & Co. The banks were also advised by Cooley LLP on aspects of US...
Abivax’ €49.2 Million Financing
Foley & Lardner LLP represented TCG Crossover on the deal while Dechert advised Abivax. TCG Crossover (TCGX) acted as the lead investor in the successful, oversubscribed EUR...
Abivax’s €85 Million Funding Round
Dechert advised Abivax on the deal. Abivax, a Euronext Paris listed clinical-stage biotechnology company, executed its oversubscribed capital increase of €60 million and convertible bonds of...